Open Your FREE Demat Account Now!

Gennex Laboratories Ltd. Share Price

NSE
BSE

BSE : 531739

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹

High

₹

Price Summary

Previous Close ₹9.80
Day's Range ₹9.70 - ₹10.07
Open ₹10.06
52 Week Range ₹07.05 - ₹17.25
Volume 2,50,950
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 24.82
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 12.28
TTM EPS (₹) 0.80
P/E Ratio 15.12
Book Value(₹) 1.05
PAT Margin (%) 11.60
Face Value (₹) 1.00
ROCE(%) 12.49

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 341.78 1379.03
Expenses N/A N/A
PBT 58.67 213.99
Operating profit 0.0 0.0
Net profit 50.16 181.25

Shareholding Pattern

Promoters (% Holding)

23.63%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

76.37%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.00%

About Gennex Laboratories Ltd.

Founded 1990
Managing Director Arihant Baid

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,34,279.63 1,810.00 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,46,737.12 9,294.40 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,81,129.27 4,761.95 3,480.60 - 3,480.60
Lenskart Solutions Ltd. 1,20,264.32 685.00 0.00 - 0.00
Apollo Hospitals Enterprise Ltd. 1,16,695.63 8,116.00 6,696.50 - 6,696.50
Zydus Lifesciences Ltd. 1,14,239.13 1,145.25 835.50 - 835.50
Cipla Ltd. 1,08,808.05 1,346.85 1,165.70 - 1,165.70
Laurus Labs Ltd. 1,07,468.10 1,989.00 843.00 - 843.00
Mankind Pharma Ltd. 1,04,376.49 2,527.00 1,909.70 - 1,909.70
Dr. Reddy's Laboratories Ltd. 1,00,169.98 1,200.10 1,101.00 - 1,101.00
no-content No Records Found

Latest News

Sep
22
2026
EQUITY Posted on Sep 22nd 2026

Gennex Laboratories informs about closure of trading window

In pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Gennex Laboratories has informed that the Trading Window for dealing in the securities of the Company shall remain closed from October 01, 2026 till 48 hours after the public announcement through Board of Directors in their Meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Half year ended on September 30, 2026 along with other matters for which trading window is required to be closed. The Board Meeting date to approve the Un-audited Standalone and Consolidated financial results of the Company for the Second Quarter and Half year ended on September 30, 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window. 
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

Soni Medicare informs about AGM voting results

Pursuant to the requirements of Regulation 44(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Soni Medicare has enclosed the details regarding voting results of the business transacted as per Notice of the 38th Annual General Meeting (AGM) of the Company held on September 29, 2025 at 3.00 PM at the registered office of the company at 38, Kanota Bagh, Jawahar Lal Nehru Marg, Jaipur RJ 302004 IN. They are also enclosing the consolidated report of the Scrutinizer on the remote e-voting and voting through poll at the AGM. The above is also being uploaded on the Company’s website www.sonihospitals.com. The Voting Results have also been uploaded in XBRL format on BSE portal.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

Soni Medicare informs about scrutinizers report

Pursuant to the requirements of Regulation 44(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Soni Medicare has enclosed the details regarding voting results of the business transacted as per Notice of the 38th Annual General Meeting (AGM) of the Company held on September 29, 2025 at 3.00 PM at the registered office of the company at 38, Kanota Bagh, Jawahar Lal Nehru Marg, Jaipur RJ 302004 IN. They are also enclosing the consolidated report of the Scrutinizer on the remote e-voting and voting through poll at the AGM. The above is also being uploaded on the Company’s website www.sonihospitals.com. The Voting Results have also been uploaded in XBRL format on BSE portal.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

Deccan Health Care informs about scrutinizers report

Pursuant to Regulation 44(3) of the Listing Regulations, Deccan Health Care has enclosed the details regarding the consolidated voting results on the businesses transacted at the 30th Annual General Meeting of the Company held on Wednesday, September 30, 2026 for the FY 2025-26, in the prescribed format along with the consolidated report of the Scrutinizer on remote e-voting and e-voting at the AGM.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

Amanta Healthcare informs about disclosure

Amanta Healthcare has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirit Desai.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Gennex Laboratories Ltd. ?

The current share price of Gennex Laboratories Ltd. is ₹9.80 as of 2026-10-01.

The market capitalisation of Gennex Laboratories Ltd. is ₹238.09 as of 2026-10-01.

The 1-year return of Gennex Laboratories Ltd. is -2.18% as of 2026-10-01.

The P/E ratio of Gennex Laboratories Ltd. is 15.12 as of 2026-10-03.

The 52-week high and low of Gennex Laboratories Ltd. are ₹17.25 and ₹7.05, respectively, as of 2026-10-01.

The dividend yield of Gennex Laboratories Ltd. is 0.0% as of2026-10-01.

You can buy Gennex Laboratories Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Gennex Laboratories Ltd. is Arihant Baid.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore